Business Wire

Quantum XChange Advances EUCC Milestone and Enterprise Scalability with Latest Release of Phio TX

24.2.2026 13:00:00 CET | Business Wire | Press Release

Share

Quantum XChange today announced the latest release of its cryptographic management platform Phio TX® which introduces a new European Union Cybersecurity Certification (EUCC) compliance mode and significant enhancements to its Hive architecture to support massive-scale, distributed deployments.

The release marks a critical milestone toward full EUCC validation for Phio TX and reinforces the company’s commitment to meeting rigorous international security standards for customers operating in regulated European markets.

EUCC is a European Union–wide certification framework based on Common Criteria (ISO/IEC 15408), providing independent evaluation of Information and Communications Technology (ICT) products against high EU cybersecurity standards. Similar in importance to FIPS validation in the United States, EUCC validation is increasingly critical for organizations handling sensitive or regulated data. Phio TX’s new EUCC compliance mode introduces additional product hardening controls, including restrictions on SSH/TLS connections to EUCC-defined cipher suites, strengthening cryptographic assurance and regulatory alignment.

“Cybersecurity certification is a prerequisite for doing business in Europe,” said Eddy Zervigon, CEO of Quantum XChange. “With EUCC compliance mode in Phio TX we’re giving customers a practical path to meet emerging EU requirements while strengthening their defenses against AI- and quantum-driven threats.”

In parallel, Quantum XChange expanded the scalability of its Hive intelligent middleware. Originally introduced in Phio TX version 4.5, the Hive delivers unified key management across distributed nodes, enabling fault tolerance and load balancing while integrating multiple quantum-safe key distribution methods including Post-Quantum Cryptography (PQC) and Quantum Key Distribution (QKD) within a single framework.

The Phio TX 4.5.3 release adds new hub, spoke, and entropy roles designed to support deployments spanning tens of thousands of nodes, including spokes operating behind dynamic IP addresses—common in large enterprise, telecom, and government networks. These enhancements improve operational resilience and simplify cryptographic management at scale.

“Across Europe, quantum-safe migration is accelerating—driven not only by EUCC, but by broader NIS2 obligations, growing data sovereignty requirements, and increasing awareness of Harvest Now, Decrypt Later risks,” said Fabien Adouani, Vice President of Business Development, Europe, at Quantum XChange. “With this Phio TX release, we’re helping organizations align with evolving EU standards while deploying a scalable, crypto-agile architecture that protects critical data today and prepares networks for the post-quantum future.”

Phio TX is Quantum XChange’s cryptographic management platform designed to secure the network layer—the largest attack surface—by separating key generation and delivery from data transmission. This architectural approach strengthens existing encryption infrastructure and enables seamless migration to post-quantum cryptography without costly rip-and-replace upgrades. To request a product demonstration go to: https://info.quantumxc.com/lp-request-demo.

About Quantum XChange
Quantum XChange® empowers leading government agencies and commercial enterprises to secure sensitive network data from advances in AI and quantum computing by protecting their data in motion today and for the post-quantum world. The company’s cryptographic management platform, Phio TX®, provides an open, secure, and flexible architecture solution.

For more information, visit www.quantumxc.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260224335506/en/

Contacts

Media Contact:
April Burghardt
PR Consultant
april.burghardt@quantumxc.com
646-246-0484

(c) 2024 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

AI Meets Traditional Culture: Huangshan Captures Widespread Attention at ITB Berlin7.3.2026 10:22:00 CET | Press Release

Huangshan, one of China’s most iconic scenic destinations, drew significant attention at this year’s ITB by presenting a compelling fusion of traditional Chinese culture and cutting-edge artificial intelligence under the slogan “The world of Huangshan is for the world.” This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260307909978/en/ International visitor admires Huangshan cultural and creative exhibits at the Huangshan stand during ITB Berlin. Located in eastern China’s Anhui Province, Huangshan is famed for its “Five Natural Wonders” — fantastic pines, grotesque rocks, sea of clouds, hot spring and winter snow. The mountain is widely regarded as one of China’s greatest mountain landscapes. It is also a rare natural heritage site that simultaneously holds multiple international designations, including UNESCO World Cultural and Natural Heritage status, a UNESCO Global Geopark and a World Biosphere Reserve. At ITB, the Huangsh

Incyte Announces the European Commission Approval of Zynyz ® (retifanlimab) for the First-Line Treatment of Advanced Squamous Cell Carcinoma of the Anal Canal (SCAC)6.3.2026 22:42:00 CET | Press Release

Incyte (Nasdaq:INCY) today announced that the European Commission (EC) has approved Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (platinum-based chemotherapy) for the first-line treatment of adult patients with metastatic or with inoperable locally recurrent squamous cell carcinoma of the anal canal (SCAC). “The EC approval of Zynyz marks an important step forward for patients with advanced SCAC, a rare cancer for which meaningful treatment advances have not occurred in several decades,” said Bill Meury, President and Chief Executive Officer, Incyte. “As the first PD-1 immunotherapy approved in Europe in combination with platinum-based chemotherapy in the first-line setting, Zynyz helps expand the standard-of-care options available to clinicians and underscores our commitment to delivering innovative medicines that can have an impact for patients.” The EC decision follows the January 2026 positive opinion received from the European Medicines Agency’s Committee f

Dfns Launches Payouts6.3.2026 21:27:00 CET | Press Release

Dfns today announced the launch of Payouts, a new API enabling institutions to convert stablecoins to fiat and route payouts across multiple bank accounts while keeping wallet-level governance and controls in place. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260305327930/en/ Convert stablecoins to fiat and settle payouts to bank accounts in 94 countries, today. Solving the problem of single-rail off-ramps Today, most fintechs and institutions still hard-wire a single payout provider into their stack, or rely on vertically integrated models that bundle routing, pricing, custody, and settlement together. That approach may be convenient early on, but it creates structural problems at scale: weak price discovery because there is no competitive pressure on margins, limited auditability because routing decisions are opaque, and operational fragility because a single provider degradation in any corridor requires architectural i

Klarna Group Plc Clarifies Mechanics of March 9 Lock-Up Expiration6.3.2026 20:23:00 CET | Press Release

Klarna Group plc (NYSE: KLAR) today issues the following clarification to ensure investors and market participants have accurate information regarding the mechanics of its lock-up expiration on March 9, 2026, the processes required before pre-IPO shares can be traded on the NYSE, and the prior liquidity opportunities already available to shareholders. This release contains only factual descriptions of the Company's share structure and applicable processes. It does not constitute guidance or a projection of any kind regarding future trading volumes, share price, or the intentions of any shareholder and speaks only as of the date of this press release. 1. 335 million locked-up shares — but two different categories Of the 378 million total ordinary shares outstanding, approximately 335 million are subject to lock-up restrictions expiring March 9, 2026. However, these shares fall into two distinct categories governed by separate sets of regulations. A. 159 million shares (48% of locked-up

Lone Star Funds Announces Agreement to Acquire the Capsules & Health Ingredients Division of Lonza Group AG6.3.2026 18:30:00 CET | Press Release

Lone Star Funds (“Lone Star”) today announced that an affiliate of Lone Star Fund XII, L.P. has entered into a definitive agreement to acquire the Capsules & Health Ingredients (“CHI”) division of Lonza Group AG. As part of the transaction, Lonza will retain a 40% equity position in the business. Headquartered in Basel, Switzerland, CHI operates globally across the Americas, Europe and Asia Pacific. The business comprises three segments: Hard Empty Capsules: leading global manufacturer of gelatin and plant-based capsules offering a broad range of innovative solutions for pharmaceutical and nutraceutical customers. Dosage Form Solutions: end-to-end development and manufacturing platform serving nutraceutical and pharmaceutical customers. Health Ingredients: provider of branded, science-backed nutrition ingredients serving joint health, energy and active lifestyle markets. Lone Star believes CHI is a high-quality, globally recognized platform with strong technical capabilities, different

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye